Skip to content

effect of herbal drug on respiratoty infection in asthmatic children

Evaluation the clinical effects of short –course herbal drug consist of Honey and zufa on Asthma symptoms and Exacerbation due to viral respiratory infection in Children with mild intermittent Asthma

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201608314976N5
Enrollment
50
Registered
2017-07-22
Start date
2015-09-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

asthma. chronic obstructive asthma

Interventions

Intervention 1: interbention group: Compounds containing honey and hyssop herb extracts, hibiscus, thyme narrow, and jujube Khorasani violets, dried figs, licorice, mallow, veneris witch was produced
Treatment - Drugs
interbention group: Compounds containing honey and hyssop herb extracts, hibiscus, thyme narrow, and jujube Khorasani violets, dried figs, licorice, mallow, veneris witch was produced by pharmacist pr
control group: placebo (a substance like herbs with the same shape,Odor, design and color ) witch was produced by pharmacist professor in Emam-Reza pharmacy and with dose of 5 milliliter every 8 hour

Sponsors

mashhad university of medical science
Lead Sponsor

Eligibility

Sex/Gender
All
Age
7 Years to 12 Years

Inclusion criteria

Inclusion criteria: inclusion criteria: age of 7 to 12 years, mild to moderate asthma, acute viral upper respiratory tract infection, absence of congenital anomalies, absence of any other disease. exclusion criteria: bacterial infection, drug reaction, inadequate compliance of patient or family in follow up or drug consumption.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Cough. Timepoint: 0 and 3rd 7th and 14teen days. Method of measurement: numbers.;Awaking during sleep. Timepoint: day 0,3,7,14. Method of measurement: number.

Secondary

MeasureTime frame
PEFR (Peak Expirometry Flow Rate) changes. Timepoint: 0 3rd days. Method of measurement: Peak Expirometry Flow Rate device.;Needing to adjuant treatment ( montelukast). Timepoint: day3,7,14. Method of measurement: yes or no.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHamid Ahanchian

Mashhad University of Medical Sciences

Ahanchianh@mums.ac.ir+98 51 1801 2469

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026